Mason Carrico
Stock Analyst at Stephens & Co.
(3.56)
# 907
Out of 5,182 analysts
71
Total ratings
45.59%
Success rate
8.13%
Average return
Main Sectors:
Stocks Rated by Mason Carrico
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintains: Overweight | $197 → $235 | $208.40 | +12.76% | 6 | Nov 13, 2025 | |
| PACB Pacific Biosciences of California | Maintains: Overweight | $1.8 → $2 | $1.69 | +18.34% | 6 | Nov 10, 2025 | |
| NEO NeoGenomics | Maintains: Overweight | $6.5 → $11 | $8.35 | +31.74% | 2 | Sep 2, 2025 | |
| VCEL Vericel | Reiterates: Overweight | $67 | $35.68 | +87.78% | 3 | Jun 16, 2025 | |
| ILMN Illumina | Reiterates: Overweight | $105 | $134.50 | -21.93% | 8 | May 20, 2025 | |
| TXG 10x Genomics | Reiterates: Overweight | $14 | $26.08 | -46.32% | 6 | May 15, 2025 | |
| CDNA CareDx | Reiterates: Overweight | $40 | $21.42 | +86.74% | 10 | May 5, 2025 | |
| GKOS Glaukos | Maintains: Overweight | $140 → $115 | $124.79 | -7.85% | 1 | May 2, 2025 | |
| VCYT Veracyte | Reiterates: Overweight | $45 | $33.80 | +33.14% | 7 | Mar 26, 2025 | |
| GH Guardant Health | Reiterates: Overweight | $55 | $90.36 | -39.13% | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $6 | $4.61 | +30.15% | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $17 | $25.08 | -32.22% | 2 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $52 | $67.08 | -22.48% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $20 | $5.08 | +293.70% | 4 | Jan 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $41 | $25.05 | +63.67% | 7 | Jan 2, 2025 |
Natera
Nov 13, 2025
Maintains: Overweight
Price Target: $197 → $235
Current: $208.40
Upside: +12.76%
Pacific Biosciences of California
Nov 10, 2025
Maintains: Overweight
Price Target: $1.8 → $2
Current: $1.69
Upside: +18.34%
NeoGenomics
Sep 2, 2025
Maintains: Overweight
Price Target: $6.5 → $11
Current: $8.35
Upside: +31.74%
Vericel
Jun 16, 2025
Reiterates: Overweight
Price Target: $67
Current: $35.68
Upside: +87.78%
Illumina
May 20, 2025
Reiterates: Overweight
Price Target: $105
Current: $134.50
Upside: -21.93%
10x Genomics
May 15, 2025
Reiterates: Overweight
Price Target: $14
Current: $26.08
Upside: -46.32%
CareDx
May 5, 2025
Reiterates: Overweight
Price Target: $40
Current: $21.42
Upside: +86.74%
Glaukos
May 2, 2025
Maintains: Overweight
Price Target: $140 → $115
Current: $124.79
Upside: -7.85%
Veracyte
Mar 26, 2025
Reiterates: Overweight
Price Target: $45
Current: $33.80
Upside: +33.14%
Guardant Health
Mar 26, 2025
Reiterates: Overweight
Price Target: $55
Current: $90.36
Upside: -39.13%
Mar 19, 2025
Reiterates: Overweight
Price Target: $6
Current: $4.61
Upside: +30.15%
Mar 18, 2025
Reiterates: Equal-Weight
Price Target: $17
Current: $25.08
Upside: -32.22%
Mar 6, 2025
Reiterates: Overweight
Price Target: $52
Current: $67.08
Upside: -22.48%
Jan 16, 2025
Reiterates: Equal-Weight
Price Target: $20
Current: $5.08
Upside: +293.70%
Jan 2, 2025
Reiterates: Overweight
Price Target: $41
Current: $25.05
Upside: +63.67%